These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11393122)

  • 1. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy.
    Tsai JJ; Su YC; Chan SC; Ho CK; Feng TC
    J Formos Med Assoc; 2001 Apr; 100(4):241-3. PubMed ID: 11393122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between eosinophils, activated T lymphocyte, leukotreine and the exercise-induced asthma].
    Guo Y; Sun T; Zhang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):360-4. PubMed ID: 11802990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
    Perng DW; Huang HY; Lee YC; Perng RP
    Chest; 2004 May; 125(5):1693-9. PubMed ID: 15136378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.
    Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP
    Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
    Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
    Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma.
    Park JW; Whang YW; Kim CW; Park YB; Hong CS
    Allergy Asthma Proc; 1998; 19(2):61-7. PubMed ID: 9578913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin induced asthma, urinary leukotriene E4 and zafirlukast].
    Orea Solano M; Flores Sandoval G; Machado C F; Romero H; Santos Argumedo L
    Rev Alerg Mex; 2002; 49(2):52-6. PubMed ID: 12092526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC; Brogden RN
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients.
    Cakmak G; Demir T; Gemicioglu B; Aydemir A; Serdaroglu E; Donma O
    Tohoku J Exp Med; 2004 Dec; 204(4):249-56. PubMed ID: 15572850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
    Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
    J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
    Spector SL
    Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.